Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 23 Carcinoma, Transitional Cell 15 Neoplasms 14 Ovarian Neoplasms 13 Carcinoma, Renal Cell 13 Urinary Bladder Neoplasms 12 Carcinoma, Merkel Cell 12 Squamous Cell Carcinoma of Head and Neck 11 Colorectal Neoplasms 8 Triple Negative Breast Neoplasms 7 Pancreatic Neoplasms 7 Neoplasm Metastasis 7 Melanoma 7 Stomach Neoplasms 6 Recurrence 5 Breast Neoplasms 5 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Lymphoma, Non-Hodgkin 2 Kidney Neoplasms 2 Kidney Diseases 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Ovarian Epithelial 2 Uveal Melanoma 1 Urothelial Cancer 1

Interventions

Injections 25 Carboplatin 17 Docetaxel 14 pembrolizumab 12 Paclitaxel 11 Bevacizumab 9 durvalumab 8 Cisplatin 8 Nivolumab 6 Fluorouracil 6 trifluridine tipiracil drug combination 5 tislelizumab 5 linifanib 5 Pemetrexed 5 Oxaliplatin 5 Leucovorin 5 zimberelimab 4 toripalimab 4 talazoparib 4 olaparib 4 Itraconazole 4 Irinotecan 4 Gemcitabine 4 Capecitabine 4 tremelimumab 3 sotorasib 3 sintilimab 3 fludarabine 3 depatuxizumab 3 atezolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Solid Tumors × avelumab × Clear all

NCT02994953 2024-09-20

COMBO

EMD Serono

Phase 1 Terminated

52 enrolled 34 charts

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡